After participating in this educational activity, attendees should be able to:
1. Recall the various probable generation pathways of chronic migraines.
2. Identify appropriate pharmacotherapy options for chronic migraine prophylaxis
3. Discuss primary literature regarding the effective use of galcanezumab in chronic migraine prophylaxis
Geena Eglin, PharmD
PGY1 Community Pharmacy Resident
Baystate Medical Center
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
PGR 3-4 Chronic Migraine Prophylaxis.pdf
- 1.00 ACPE Contact Hours